• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

梗死样坏死:一种在结直肠癌肝转移患者接受围手术期化疗后出现的独特坏死形式。

Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy.

机构信息

Department of Pathology, University of Western Ontario, London, ON, Canada.

出版信息

Am J Surg Pathol. 2012 Apr;36(4):570-6. doi: 10.1097/PAS.0b013e31824057e7.

DOI:10.1097/PAS.0b013e31824057e7
PMID:22301494
Abstract

The response of colorectal adenocarcinoma liver metastases to perioperative chemotherapy can be assessed histologically in partial hepatectomy specimens. Necrosis in this scenario may represent a lack of treatment effect or a therapeutic response to chemotherapy. This study sought to validate the histologic classification of necrosis into 2 types: usual necrosis (UN) representing an absence of treatment effect, and infarct-like necrosis (ILN) representing a therapeutic response to chemotherapy. Tumor regression grade (TRG) is a previously described prognosticating method that estimates tumor replacement by fibrosis. We incorporated ILN into a modified TRG (mTRG) and compared its performance as a prognostic factor against TRG. A retrospective clinical and histologic review was undertaken of all partial hepatectomies performed for colorectal liver metastases at our center between 2004 and 2010. Clinicopathologic features were compared between the 2 types of necrosis, including survival stratified by TRG and mTRG. A total of 109 cases were reviewed, with 46 patients receiving perioperative chemotherapy. ILN was identified in 12 cases, and all of these cases were associated with perioperative chemotherapy. ILN was significantly associated with perioperative treatment with bevacizumab. In patients receiving perioperative chemotherapy, those with ILN had superior disease-free survival compared with those with UN (P=0.047). mTRG1 to 2 scores were associated with significantly better survival compared with mTRG3 to 5 scores. In contrast, use of TRG did not demonstrate a significant difference in disease-free and overall survival. ILN represents a form of treatment effect and should be distinguished from UN. A modified grading system that incorporates ILN may enhance the prognostic utility of TRG.

摘要

结直肠癌肝转移患者的围手术期化疗疗效可通过部分肝切除标本的组织学评估。在这种情况下,坏死可能代表缺乏治疗效果或对化疗的治疗反应。本研究旨在验证将坏死分为两种类型的组织学分类:通常的坏死(UN)代表缺乏治疗效果,而类似梗塞的坏死(ILN)代表对化疗的治疗反应。肿瘤退缩分级(TRG)是一种先前描述的预后方法,用于估计纤维化对肿瘤的替代程度。我们将 ILN 纳入改良的 TRG(mTRG)中,并比较其作为预后因素的表现与 TRG。对 2004 年至 2010 年期间在我们中心进行的所有结直肠癌肝转移部分肝切除术的临床和组织学回顾进行了回顾性分析。比较了两种类型的坏死的临床病理特征,包括按 TRG 和 mTRG 分层的生存情况。共回顾了 109 例病例,其中 46 例接受了围手术期化疗。在 12 例中发现了 ILN,所有这些病例均与围手术期化疗相关。ILN 与围手术期贝伐单抗治疗显著相关。在接受围手术期化疗的患者中,ILN 患者的无病生存率明显优于 UN 患者(P=0.047)。mTRG1 至 2 评分与显著更好的生存相关,而 mTRG3 至 5 评分则相反。相比之下,TRG 的使用并未在无病生存和总生存方面显示出显著差异。ILN 代表一种治疗效果,应与 UN 区分开来。一种纳入 ILN 的改良分级系统可能会提高 TRG 的预后实用性。

相似文献

1
Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy.梗死样坏死:一种在结直肠癌肝转移患者接受围手术期化疗后出现的独特坏死形式。
Am J Surg Pathol. 2012 Apr;36(4):570-6. doi: 10.1097/PAS.0b013e31824057e7.
2
Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.结直肠癌肝转移化疗后肝切除术:化疗相关肝损伤、肿瘤病理反应和微转移对长期生存的影响。
Ann Surg. 2013 Nov;258(5):731-40; discussion 741-2. doi: 10.1097/SLA.0b013e3182a6183e.
3
Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone.与单纯化疗相比,结直肠肝转移灶手术切除不完全后再进行化疗会降低生存率。
J Exp Clin Cancer Res. 2006 Sep;25(3):313-9.
4
Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.新辅助化疗后切除治疗结直肠肝转移瘤的患者中,窦性阻塞综合征会损害长期预后。
Ann Surg Oncol. 2011 Feb;18(2):421-30. doi: 10.1245/s10434-010-1317-4. Epub 2010 Sep 16.
5
Morphological aspects of the hepatic response to neoadjuvant therapy.肝脏对新辅助治疗反应的形态学方面
Pathol Res Pract. 2015 Sep;211(9):665-70. doi: 10.1016/j.prp.2015.06.007. Epub 2015 Jun 16.
6
Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.新辅助化疗(包括贝伐珠单抗)后行肝切除术仍然安全:一项病例对照研究。
Ann Surg. 2010 Jul;252(1):124-30. doi: 10.1097/SLA.0b013e3181deb67f.
7
[Specific treatment situations in metastatic colorectal cancer].[转移性结直肠癌的特定治疗情况]
Onkologie. 2010;33 Suppl 4:8-18. doi: 10.1159/000308447. Epub 2010 Apr 23.
8
Current treatment of colorectal liver metastases.结直肠癌肝转移的当前治疗方法。
Tech Coloproctol. 2004 Nov;8 Suppl 1:s174-6. doi: 10.1007/s10151-004-0148-3.
9
Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.在新化疗方案时代,肝门淋巴结受累的结直肠癌肝转移患者肝切除术后的长期生存情况。
Ann Surg. 2009 Jun;249(6):879-86. doi: 10.1097/SLA.0b013e3181a334d9.
10
Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy.初次肝切除术后结直肠癌肝转移患者辅助化疗指征的重新审视
Ann Surg Oncol. 2014 Jan;21(1):139-46. doi: 10.1245/s10434-013-3310-1.

引用本文的文献

1
Synthetic tumor extracellular volume as a predictive biomarker for colorectal liver metastasis patients prior to curative hepatectomy.合成肿瘤细胞外容积作为结直肠癌肝转移患者根治性肝切除术前的预测生物标志物。
Eur Radiol. 2025 Mar 24. doi: 10.1007/s00330-025-11503-6.
2
Evaluation of the Relationship Between Portal Vein Diameter and Colorectal Liver Metastases on Computed Tomography.评价门静脉直径与 CT 扫描下结直肠癌肝转移的关系。
In Vivo. 2024 Sep-Oct;38(5):2471-2477. doi: 10.21873/invivo.13717.
3
Beyond CT: A Case Analysis of Serial [18F]FDG PET/CT for Assessment of Necrosis and Early Recurrence in Colorectal Liver Metastases.
超越CT:一例关于连续[18F]FDG PET/CT评估结直肠癌肝转移坏死和早期复发的病例分析
Cureus. 2023 Dec 31;15(12):e51393. doi: 10.7759/cureus.51393. eCollection 2023 Dec.
4
Assessment of the response to systemic treatment of colorectal liver metastases on cross-sectional imaging - a systematic review.基于横断面成像评估结直肠癌肝转移全身治疗的疗效——一项系统评价
Pol J Radiol. 2023 Nov 8;88:e512. doi: 10.5114/pjr.2023.132884. eCollection 2023.
5
MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423).磁共振成像表观扩散系数(ADC)作为肿瘤反应的生物标志物:结直肠癌肝转移患者的影像-病理相关性(欧洲癌症研究与治疗组织1423)
Cancers (Basel). 2023 Jul 12;15(14):3580. doi: 10.3390/cancers15143580.
6
Evaluation of peripheral enhancement on contrast-enhanced computed tomography and corresponding pathological findings in colorectal liver metastases after preoperative chemotherapy.术前化疗后结直肠癌肝转移患者的对比增强计算机断层扫描外周强化评估及相应病理结果
Pol J Radiol. 2023 May 16;88:e251-e255. doi: 10.5114/pjr.2023.127611. eCollection 2023.
7
Peritoneal regression grading score (PRGS): first evidence for independent predictive and prognostic significance.腹膜消退分级评分(PRGS):独立预测和预后意义的首个证据。
Pleura Peritoneum. 2023 May 18;8(2):55-63. doi: 10.1515/pp-2023-0014. eCollection 2023 Jun.
8
Infarct Like Necrosis of Colorectal Liver Metastasis Without Chemotherapy: A Rare Phenomenon.未接受化疗的结直肠癌肝转移灶样梗死坏死:一种罕见现象
Clin Pathol. 2022 Dec 22;15:2632010X221145537. doi: 10.1177/2632010X221145537. eCollection 2022 Jan-Dec.
9
Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial.切除的结直肠癌肝转移灶的病理评估:II期ATOM试验中mFOLFOX6联合贝伐单抗与mFOLFOX6联合西妥昔单抗的对比
Cancers (Basel). 2022 Sep 9;14(18):4392. doi: 10.3390/cancers14184392.
10
Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and H-MR spectroscopy compared with histology (subgroup in the RAXO trial).结直肠癌肝转移新辅助或转化治疗的疗效评价:前瞻性多中心随访研究,采用 MRI、扩散加权成像和 H-MR 光谱与组织学比较(RAXO 试验的亚组)。
ESMO Open. 2021 Aug;6(4):100208. doi: 10.1016/j.esmoop.2021.100208. Epub 2021 Jul 26.